[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617336":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":27,"centralContacts":31,"locations":37,"responsibleParty":53,"collaborators":24,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":61,"acronym":24,"eligibilityCriteria":62,"healthyVolunteers":63,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":24,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":24,"overallStatus":40,"whyStopped":24,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Uskudar University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"control","ACTIVE_COMPARATOR","patients receiving normal routine pharmacological treatment without any special intervention",[13],"Other: control",{"label":15,"type":16,"description":17,"interventionNames":18},"Extracorporeal Shockwave Therapy","EXPERIMENTAL","Patients receiving Extracorporeal Shockwave Therapy treatment",[19],"Other: Extracorporeal Shockwave Therapy",[21,25],{"type":6,"name":15,"description":22,"armGroupLabels":23,"otherNames":24},"Extracorporeal Shockwave Therapy will follow a standard protocol. The treatment is planned as a total of 8 sessions (3000 pulses per session, 2.5 bar pressure, 15 Hz frequency) twice a week using a radial shockwave device. Focusing will be done on the penile shaft via gel according to the plaque localization, and shock waves will be applied to the plaque area.",[15],null,{"type":6,"name":9,"description":11,"armGroupLabels":26,"otherNames":24},[9],[28],{"name":29,"affiliation":5,"role":30},"Aziz Azizov","STUDY_CHAIR",[32],{"name":33,"role":34,"phone":35,"phoneExt":24,"email":36},"Ömer ŞEVGİN","CONTACT","+905069787535","omer.sevgin@uskudar.edu.tr",[38],{"facility":39,"status":40,"city":41,"state":24,"zip":24,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Koreya Serq Tebabeti","RECRUITING","Baku","Azerbaijan","AZ",{"type":45,"coordinates":46},"Point",[47,48],49.89201,40.37767,{"lat":48,"lon":47},[51],{"name":29,"role":34,"phone":24,"phoneExt":24,"email":52},"azizazizovv798@gmail.com",{"type":54,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Doç.Dr.Ömer Şevgin","Assoc.Prof.Dr.","100617336","extracorporeal-shockwave-therapy-in-the-treatment-of-peyronies-disease-100617336",false,"NCT07317297","Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease","Inclusion Criteria:\n\n* Male individuals aged 18-65 years.\n* Having been diagnosed with Peyronie's Disease that has been stable (without increasing pain and curvature) for at least 6 months.\n* Presence of palpable penile plaque.\n\nExclusion Criteria:\n\n* Acute inflammatory stage (painful, progressive)\n* Having previously undergone surgery, needle therapy (e.g., Xiaflex), or Extracorporeal Shockwave Therapy for peyronie's disease.\n* Uncontrolled diabetes, severe coagulopathy, or receiving anticoagulant therapy.\n* History of penile cancer.\n* Severe erectile dysfunction.\n* Patients who are considered unable to comply with the study protocol or who cannot attend follow-up visits.",true,"MALE","18 Years","65 Years",{"count":68,"type":69},50,"ESTIMATED","INTERVENTIONAL",[72],"NA","Investigation of the effectiveness of extracorporeal shock wave therapy in the treatment of Peyronie's disease.",[75],"Peyronie Disease","2026-01-15",{"date":78,"type":79},"2026-01-16","ACTUAL",{"date":81,"type":79},"2026-01-10",{"date":83,"type":69},"2026-03-30",{"name":5,"class":6},1]